Logo

Waters' Q2 Profit Recedes, Dragging Down Shares

Jul 25, 2006
NEW YORK (GenomeWeb News) – Waters today reported that second-quarter revenue increased 6 percent as net income fell 12 percent on increased expenses, causing shares to slide 8.8 percent, or $3.75, to $38.85 in mid-afternoon trading.
 
Total receipts for the three months ended July 1 increased to $302 million from $285 million year over year. Waters said it is seeing strong demand for its Acquity UPLC technology.
 
Profit in the quarter declined to $48 million, or $.46 per share, from $54 million, or $.47 per share, last year. The company reported about $3 million in restructuring costs while expenses increased 7 percent in the quarter.
 
R&D spending increased 25 percent to about $20 million from $16 million in the year-ago period.
 
As of July 1, Waters had $490 million in cash and cash equivalents.

Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.